PRODUCT RELEASE
SAN DIEGO, CA – August 2019

NOW AVAILABLE! MRD solutions for B- and T-cell clonality tracking

PRODUCT RELEASE
SAN DIEGO, CA – August 2019

NOW AVAILABLE! MRD solutions for B- and T-cell clonality tracking

MRD Clonality

Minimal Residual Disease (MRD) is the presence of low levels of malignant cells that remain in a subject during or after treatment or when the patient is in remission. Detectable levels of cancer cells following treatment may suggest a higher probability of relapse.

LEARN MORE ⟶

MRD Clonality

Minimal Residual Disease (MRD) is the presence of low levels of malignant cells that remain in a subject during or after treatment or when the patient is in remission. Detectable levels of cancer cells following treatment may suggest a higher probability of relapse.

LEARN MORE ⟶

SHARE THIS PRODUCT RELEASE
2019-09-23T22:05:58+00:00